EX-32.1 4 exhibit321-q120251.htm EX-32.1
Exhibit 32.1
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. Section 1350)
In connection with the accompanying Quarterly Report of Akebia Therapeutics, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2025 (the “Report”), I, John P. Butler, as Chief Executive Officer and President of the Company, and I, Erik J. Ostrowski, as Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 8, 2025 | By: | /s/ John P. Butler
|  | John P. Butler
|  | President, Chief Executive Officer and Director
|  | (Principal Executive Officer)
Date: May 8, 2025 | By: | /s/ Erik J. Ostrowski
|  | Erik J. Ostrowski
|  | Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
|  | (Principal Financial Officer)